High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva

被引:57
作者
Hoetelmans, RMW
van Essenberg, M
Profijt, M
Meenhorst, PL
Mulder, JW
Beijnen, JH
机构
[1] Slotervaart Hosp, Dept Pharm & Pharmacol, NL-1066 EC Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Internal Med, NL-1066 EC Amsterdam, Netherlands
来源
JOURNAL OF CHROMATOGRAPHY B | 1998年 / 705卷 / 01期
关键词
ritonavir;
D O I
10.1016/S0378-4347(97)00500-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, ion-pair high-performance liquid chromatographic method has been developed and validated for the quantitative determination of the HIV protease inhibitor ritonavir in human plasma, cerebrospinal fluid and saliva. Sample pretreatment consisted of precipitation of proteins with acetonitrile prior to high-performance liquid chromatography with ultraviolet detection at 239 nm. The method has been validated over the range of 50 ng/ml to 50 mu g/ml with use of 100-mu l volumes of sample. The currently described assay has been used successfully for the analysis of ritonavir in plasma, cerebrospinal fluid and saliva in HIV-1 infected patients. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 10 条
[1]  
*COMM PROPR MED PR, 1996, CPMP52796
[2]   A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].
DANNER, SA ;
CARR, A ;
LEONARD, JM ;
LEHMAN, LM ;
GUDIOL, F ;
GONZALES, J ;
RAVENTOS, A ;
RUBIO, R ;
BOUZA, E ;
PINTADO, V ;
AGUADO, AG ;
DELOMAS, JG ;
DELGADO, R ;
BORLEFFS, JCC ;
HSU, A ;
VALDES, JM ;
BOUCHER, CAB ;
COOPER, DA ;
GIMENO, C ;
CLOTET, B ;
TOR, J ;
FERRER, E ;
MARTINEZ, PL ;
MORENO, S ;
ZANCADA, G ;
ALCAMI, J ;
NORIEGA, AR ;
PULIDO, F ;
GLASSMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533
[3]   Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection [J].
Hoetelmans, RMW ;
vanEssenberg, M ;
Meenhorst, PL ;
Mulder, JW ;
Beijnen, JH .
JOURNAL OF CHROMATOGRAPHY B, 1997, 698 (1-2) :235-241
[4]   Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects [J].
Hsu, A ;
Granneman, GR ;
Witt, G ;
Locke, C ;
Denissen, J ;
Molla, A ;
Valdes, J ;
Smith, J ;
Erdman, K ;
Lyons, N ;
Niu, P ;
Decourt, JP ;
Fourtillan, JB ;
Girault, J ;
Leonard, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :898-905
[5]   CALIBRATION AND VALIDATION OF LINEARITY IN CHROMATOGRAPHIC BIOPHARMACEUTICAL ANALYSIS [J].
KARNES, HT ;
MARCH, C .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (10-12) :911-918
[6]   ABT-538 IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE AND HAS HIGH ORAL BIOAVAILABILITY IN HUMANS [J].
KEMPF, DJ ;
MARSH, KC ;
DENISSEN, JF ;
MCDONALD, E ;
VASAVANONDA, S ;
FLENTGE, CA ;
GREEN, BE ;
FINO, L ;
PARK, CH ;
KONG, XP ;
WIDEBURG, NE ;
SALDIVAR, A ;
RUIZ, L ;
KATI, WM ;
SHAM, HL ;
ROBINS, T ;
STEWART, KD ;
HSU, A ;
PLATTNER, JJ ;
LEONARD, JM ;
NORBECK, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2484-2488
[7]   QUANTIFICATION OF THE ANTI-HIV DRUG SAQUINAVIR BY HIGH-SPEED ONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY [J].
KNEBEL, NG ;
SHARP, SR ;
MADIGAN, MJ .
JOURNAL OF MASS SPECTROMETRY, 1995, 30 (08) :1149-1156
[8]  
MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304
[9]  
MASSART DL, 1988, CHEMOMETRICS TXB, P84
[10]  
MOLLA A, 1996, 5 INT WORKSH HIV DRU